The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Maxilief Effervescent Tablets Paracetamol 500mg Codeine Phosphate Hemihydrate 8mg Caffeine 30mg



Clonmel Healthcare LtdPA0126/113/001

Main Information

Trade NameMaxilief Effervescent Tablets Paracetamol 500mg Codeine Phosphate Hemihydrate 8mg Caffeine 30mg
Active SubstancesParacetamol
Codeine phosphate hemihydrate
Caffeine
Dosage FormEffervescent tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/113/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics

Status

License statusAuthorised
Licence Issued11/10/2002
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceRetail sale through pharmacies only in blister packs in a maximum pack size of 24 units. Prescription-only medicine in packs containing more than 24 units.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back